VVUS

VIVUS, Inc. News Headlines

$4.2
*  
unch
unch
Get VVUS Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Arena And VIVUS: A Case Study In Small-Cap Pharma
8/18/2014 7:53:00 AM - Seeking Alpha

2nd Half Of 2014 Biotechnology Catalysts--Part 4
8/17/2014 8:28:00 PM - Seeking Alpha

Belviq Sales Flatten Out But Edge Above Qsymia
8/15/2014 4:10:00 PM - Seeking Alpha

FDA Data: Good News For One Anti-Obesity Company, Not So Good For Another
8/15/2014 9:15:00 AM - Seeking Alpha

Auxilium Posts Wider-than-Expected Loss, Outlook Maintained - Analyst Blog
8/12/2014 2:10:00 PM - Zacks.com

Arena's Belviq Bucks Seasonality With 3.6% Week Over Week Gain
8/8/2014 1:28:00 PM - Seeking Alpha

VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales - Analyst Blog
8/8/2014 11:00:00 AM - Zacks.com

Vivus Beats The Street - Still Has A Loss
8/8/2014 10:04:00 AM - Seeking Alpha

Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog
8/8/2014 9:20:00 AM - Zacks.com

Orexigen Hits Expectations But That Is Not The Big News
8/7/2014 1:25:00 PM - Seeking Alpha

Will Emergent BioSolutions (EBS) Earnings Disappoint in Q2? - Analyst Blog
8/6/2014 5:45:00 PM - Zacks.com

Will Horizon Pharma (HZNP) Earnings Miss Estimates in Q2? - Analyst Blog
8/6/2014 5:00:00 PM - Zacks.com

Will Mylan (MYL) Earnings in Q2 Disappoint Expectations? - Analyst Blog
8/6/2014 4:35:00 PM - Zacks.com

2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha

Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog
8/4/2014 11:10:00 AM - Zacks.com

Possible Delay In Orexigen Approval Process In Europe
7/31/2014 9:54:00 AM - Seeking Alpha

Cramer's Lightning Round - General Electric Needs To Bring Good Things To Life (7/15/14)
7/16/2014 6:21:00 AM - Seeking Alpha

Arena Pharmaceuticals-Eisai Boost Obesity Drug Sales Force - Analyst Blog
7/11/2014 4:45:00 PM - Zacks.com

VIVUS Inc. (VVUS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
7/8/2014 8:00:00 AM - Zacks.com

Arena's Belviq Sales Flat Again
6/27/2014 12:37:00 PM - Seeking Alpha

The Anti-Obesity Space Is Not As Simple As Some Think
6/20/2014 11:34:00 AM - Seeking Alpha

What Will It Take For Arena Stock To Rise?
6/16/2014 4:19:00 PM - Seeking Alpha

Vivus Suit Preserves Exclusivity Of Qsymia - For Now
6/13/2014 2:56:00 PM - Seeking Alpha

U.S. Hot Stocks: Hot Stocks to Watch
6/13/2014 8:36:00 AM - Dow Jones Business News

FDA Delays Decision On Orexigen Anti-Obesity Drug - What This Means To The Stock
6/11/2014 9:28:00 AM - Seeking Alpha